BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Options Update: Human Genome options expensive; shares up 215%]]>http://www.bloggingstocks.com/2009/07/20/options-update-human-genome-options-expensive-shares-up-215-i/http://www.bloggingstocks.com/2009/07/20/options-update-human-genome-options-expensive-shares-up-215-i/http://www.bloggingstocks.com/2009/07/20/options-update-human-genome-options-expensive-shares-up-215-i/#commentsFiled under:

Human Genome (NASDAQ: HGSI) is recently trading at $11.07 in pre-open trading, above its close of $3.32. Human Genome Sciences and GlaxoSmithKline (NYSE: GSK) announced that BENLYSTA met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus. HGSI August 2.5 straddle is priced at $2.45, October 2.5 straddle is priced at $2.75, January 2.5 straddle is priced at $3.25 according to Track Data, suggesting large price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Options Update: Human Genome options expensive; shares up 215% originally appeared on BloggingStocks on Mon, 20 Jul 2009 08:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>BENLYSTAGlaxoSmithKlinegskhgsiHuman GenomeHumanGenomeinthenewsoption impplied volatilityOptionImppliedVolatilityMon, 20 Jul 2009 08:00:00 EST